1
|
McGrogan A, Madle GC, Seaman HE and de
Vries CS: The epidemiology of Guillain-Barŕe syndrome worldwide. A
systematic literature review. Neuroepidemiology. 32:150–163. 2009.
View Article : Google Scholar
|
2
|
Huang WT, Yang HW, Liao TL, et al: Safety
of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a
self-controlled case series study. PLoS One. 8:e588272013.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Salmon DA, Proschan M, Forshee R, et al:
Association between Guillain-Barré syndrome and influenza A (H1N1)
2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Lancet. 381:1461–1468. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang D, Zhang G, Hayden MS, et al: A
toll-like receptor that prevents infection by uropathogenic
bacteria. Science. 303:1522–1526. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Eom SH, Gu GJ, Suh CW, et al: Suppression
of inducible nitric oxide synthase expression induced by Toll-like
receptor agonists by (E)-1-(2-(2-nitrovinyl)phenyl) pyrrolidine.
Int Immunopharmacol. 17:205–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Santaolalla R, Sussman DA, Ruiz JR, et al:
TLR4 activates the β-catenin pathway to cause intestinal neoplasia.
PLoS One. 8:e632982013. View Article : Google Scholar
|
7
|
Arbour NC, Lorenz E, Schutte BC, et al:
TLR4 mutations are associated with endotoxin hyporesponsiveness in
humans. Nat Genet. 25:187–191. 2000. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang ZY, Zhang Z and Schluesener HJ:
FTY720 attenuates lesional interleukin-17 (+) cell accumulation in
rat experimental autoimmune neuritis. Neuropathol Appl Neurobiol.
35:487–495. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang ZY, Zhang Z and Schluesener HJ:
Toll-like receptor-2, CD14 and heat-shock protein 70 in
inflammatory lesions of rat experimental autoimmune neuritis.
Neuroscience. 159:136–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Reynolds JM, Pappu BP, Peng J, et al:
Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T
helper 17 responses and regulates the pathogenesis of autoimmune
disease. Immunity. 32:692–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Islam Z, Gilbert M, Mohammad QD, et al:
Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh:
ganglioside mimicry and cross-reactive antibodies. PLoS One.
7:e439762012. View Article : Google Scholar
|
12
|
Heikema AP, Koning RI, Duarte dos Santos
Rico S, et al: Enhanced sialoadhesin-dependent uptake of
Guillain-Barre syndrome-associated Campylobacter jejuni strains by
human macrophages. Infect Immun. 81:2095–2103. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Nakamura M, Funami K, Komori A, et al:
Increased expression of Toll-like receptor 3 in intrahepatic
biliary epithelial cells at sites of ductular reaction in diseased
livers. Hepatol Int. 2:222–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kaida K, Ariga T and Yu RK:
Antiganglioside antibodies and their pathophysiological effects on
Guillain-Barr e syndrome and related disorders-A review.
Glycobiology. 19:676–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hans M and Hans VM: Toll-like receptors
and their dual role in periodontitis: a review. J Oral Sci.
53:263–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Deng YN and Zhou WB: Expression of TLR4
and TLR9 mRNA in Lewis rats with experimental allergic neuritis.
Neuroimmunomodulation. 14:337–343. 2007. View Article : Google Scholar
|
17
|
Marta M, Andersson A, Isaksson M, et al:
Unexpected regulatory roles of TLR4 and TLR9 in experimental
autoimmune encephalomyelitis. Eur J Immunol. 38:565–575. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18
|
van Koningsveld R, Steyerberg EW, Hughes
RA, et al: A clinical prognostic scoring system for Guillain-Barré
syndrome. Lancet Neurol. 6:589–594. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang YZ, Liang QH, Ramkalawan H, et al:
Expression of Toll-like receptors 2, 4 and 9 in patients with
Guillain-Barré syndrome. Neuroimmunomodulation. 19:60–68. 2012.
View Article : Google Scholar
|
20
|
Kusunoki S: Antiglycolipid antibodies in
Guillain–Barré syndrome and autoimmune neuropathies. Am J Med Sci.
319:234–239. 2000. View Article : Google Scholar : PubMed/NCBI
|
21
|
Arcila-Londono X and Lewis RA:
Guillain-Barré syndrome. Semin Neurol. 32:179–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Komatsuda A, Wakui H, Iwamoto K, et al:
Up-regulated expression of Toll-like receptors mRNAs in peripheral
blood mononuclear cells from patients with systemic lupus
erythe-matosus. Clin Exp Immunol. 152:482–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Papadimitraki ED, Choulaki C, Koutala E,
et al: Expansion of toll-like receptor 9-expressing B cells in
active systemic lupus erythematosus: implications for the induction
and maintenance of the autoimmune process. Arthritis Rheum.
54:3601–3611. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gries M, Davies L, Liu Y, Bachhuber A, et
al: Response of Toll-like receptors in experimental Guillain-Barré
syndrome: a kinetic analysis. Neurosci Lett. 518:154–160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Matsui H, Ohgomori T, Natori T, et al:
Keratan sulfate expression in microglia is diminished in the spinal
cord in experimental autoimmune neuritis. Cell Death Dis.
4:e9462013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Orlikowski D, Chazaud B, Plonquet A, et
al: Monocyte chemoat-tractant protein 1 and chemokine receptor CCR2
productions in Guillain-Barré syndrome and experimental autoimmune
neuritis. J Neuroimmunol. 134:118–127. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Boyle K, Azari MF, Cheema SS and Petrato
SS: TNF alpha mediates Schwann cell death by upregulating p75NTR
expression without sustained activation of NFkappaB. Neurobiol Dis.
20:412–427. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kurz M, Pischel H, Hartung HP and Kieseier
BC: Tumor necrosis factor-alpha-converting enzyme is expressed in
the inflamed peripheral nervous system. J Peripher Nerv Syst.
10:311–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang J, Dong H, Li B, et al: Association
of tumor necrosis factor polymorphisms with Guillain-Barré
syndrome. Eur Neurol. 58:21–25. 2007. View Article : Google Scholar
|
30
|
Zhang HL, Hassan MY, Zheng XY, et al:
Attenuated EAN in TNF-α deficient mice is associated with an
altered balance of M1/M2 macrophages. PLoS One. 7:e381572012.
View Article : Google Scholar
|
31
|
Hayashi R, Xiao W, Kawamoto M, et al:
Systemic glucocorticoid therapy reduces pain and the number of
endoneurial tumor necrosis factor-alpha (TNF alpha)-positive mast
cells in rats with a painful peripheral neuropathy. J Pharmacol
Sci. 106:559–565. 2008. View Article : Google Scholar : PubMed/NCBI
|
32
|
Sivieris, Ferrarini AM, Lolli F, et al:
Cytokine pattern in the cerebrospinal fluid from patients with GBS
and CIDP. J Neurol Sci. 147:93–95. 1997. View Article : Google Scholar
|
33
|
Vaishnavi C, Behura C, Prabhakar S, Sharma
A and Kharbanda P: Anti-ganglioside antibodies in patients with
Guillain Barré syndrome and other neurological disorders. Indian J
Med Microbiol. 31:177–179. 2013.PubMed/NCBI
|
34
|
Chatani H, Tanaka M, Nagata T, et al:
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for
immuno-globulin G anti-N-acetylgalactosaminyl-GD1a antibody. J Clin
Neurosci. 21:170–172. 2014. View Article : Google Scholar
|
35
|
Kaida K, Ariga T and Yu RK:
Antiganglioside antibodies and their pathophysiological effects on
Guillain-Barré syndrome and related disorders-a review.
Glycobiology. 19:676–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
36
|
Jacobs BC, van Doorn PA, Schmitz PI, et
al: Campylobacter jejuni infections and anti-GM1 antibodies in
Guillain-Barré syndrome. Ann Neurol. 40:181–187. 1996. View Article : Google Scholar : PubMed/NCBI
|
37
|
Koga M, Gilbert M, Takahashi M, et al:
GQ1b-seronegative Fisher syndrome: clinical features and new
serological markers. J Neurol. 259:1366–1374. 2012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lehmann HC, Lopez PH, Zhang G, Ngyuen T,
Zhang J, et al: Passive immunization with anti-ganglioside
antibodies directly inhibits axon regeneration in an animal model.
J Neurosci. 27:27–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Sheikh KA and Zhang G: An update on
pathobiologic roles of anti-glycan antibodies in Guillain-Barré
syndrome. F1000 Biol Rep. 2:212010.
|